Cargando…
Alpha-1 antitrypsin deficiency: an update on clinical aspects of diagnosis and management
Clinical heterogeneity has been demonstrated in alpha-1 antitrypsin deficiency (AATD), such that clinical suspicion plays an important role in its diagnosis. The PiZZ genotype is the most common severe deficiency genotype and so tends to result in the worst clinical presentation, hence it has been t...
Autores principales: | Santos, Gabriela, Turner, Alice M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty Opinions Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886062/ https://www.ncbi.nlm.nih.gov/pubmed/33659933 http://dx.doi.org/10.12703/b/9-1 |
Ejemplares similares
-
Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current Perspectives
por: Quinn, Mark, et al.
Publicado: (2020) -
Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil
por: Jardim, José R, et al.
Publicado: (2021) -
Alpha(1)-antitrypsin deficiency: current perspective on research, diagnosis, and management
por: Stolk, Jan, et al.
Publicado: (2006) -
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018) -
Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review
por: Edgar, Ross G, et al.
Publicado: (2017)